Daiwa raised Tesla's target price to $420.Yuncong Technology: "The R&D team of large-scale model agent products is basically dissolved" is all false information. Yuncong Technology said on the interactive platform that the company's R&D team is stable at present, and a rigorous and meticulous hierarchical division of labor system has been established for the research and development of large-scale model related products. The configuration of R&D echelon will be flexibly adjusted according to the continuous evolution of large model technology and the changes of market demand of agent products. The statements of "the No.1 position of the big model algorithm" and "the R&D team of the big model agent product is basically dissolved" mentioned in the question are false information, and the company reserves the right to pursue legal responsibility for this. The company has been unswervingly promoting the research and product development of large-scale model and agent-related technologies.Commander-in-Chief of Russian Navy: The naval sub-group of Russian nuclear forces has been completely updated.
Truck manufacturer Paccar recalled more than 220,000 American cars due to electronic system problems. The National Highway Traffic Safety Administration (NHTSA) said on Thursday that truck manufacturer Paccar recalled 220,972 cars in the United States because there was a problem with the electronic control unit (ECU), which might affect the systems related to braking and stability control. NHTSA said that the recalled vehicles included some Peterbilt and Kenworth cars produced in 2021-2025.Ankaiwei: More than 10 million chips with computing power have been shipped. According to An Kai Micro Interactive Platform, since the first generation of chips with lightweight computing power were mass-produced and shipped in 2022, more than 10 million chips with computing power have been shipped.Syria's transitional government's commitment to inclusiveness has aroused concern. On the 11th, the caretaker Prime Minister of Syria's transitional government, Mohammed Al-Bashir, promised that the transitional government would protect the rights of all ethnic groups, sects and all people. However, the transitional government was formed with the "Syrian Salvation Government" under the rule of the "Syrian Sham Liberation Armed Forces" in Idlib province, and its inclusiveness caused many concerns. (Xinhua News Agency)
Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.Institution: The Swiss National Bank does not need to cut interest rates sharply again. Melanie Debono, a macroeconomic analyst at Pantheon, wrote in a report that the Swiss National Bank does not need to cut borrowing costs sharply again. Earlier, the Swiss National Bank unexpectedly cut interest rates by 50 basis points. Most analysts had expected a more cautious rate cut of 25 basis points. Debono said that there may be further relaxation after this move, but only a little. Pantheon Macroeconomics predicts that the Swiss National Bank will cut interest rates by 25 basis points again in March next year.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide